Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 27% ± 9% | |
natural killer cell | 3 studies | 17% ± 1% | |
endothelial cell | 3 studies | 23% ± 7% | |
fibroblast | 3 studies | 21% ± 5% | |
ciliated cell | 3 studies | 21% ± 4% | |
abnormal cell | 3 studies | 20% ± 4% | |
basal cell | 3 studies | 23% ± 8% |
Insufficient scRNA-seq data for expression of KEAP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4271.84 | 1445 / 1445 | 100% | 71.73 | 183 / 183 |
thymus | 100% | 4037.25 | 653 / 653 | 100% | 87.14 | 605 / 605 |
uterus | 100% | 3545.48 | 170 / 170 | 100% | 119.28 | 459 / 459 |
brain | 100% | 3252.21 | 2639 / 2642 | 100% | 113.14 | 705 / 705 |
skin | 100% | 4322.15 | 1809 / 1809 | 100% | 77.29 | 471 / 472 |
ovary | 100% | 2658.92 | 180 / 180 | 100% | 84.25 | 429 / 430 |
prostate | 100% | 3847.69 | 245 / 245 | 100% | 93.89 | 500 / 502 |
adrenal gland | 100% | 4063.17 | 258 / 258 | 100% | 73.83 | 229 / 230 |
liver | 100% | 2778.95 | 226 / 226 | 100% | 63.73 | 404 / 406 |
breast | 100% | 3421.47 | 459 / 459 | 99% | 81.97 | 1112 / 1118 |
kidney | 100% | 2741.44 | 89 / 89 | 99% | 60.95 | 896 / 901 |
stomach | 100% | 2738.46 | 359 / 359 | 99% | 71.86 | 284 / 286 |
lung | 100% | 2965.26 | 578 / 578 | 99% | 87.52 | 1146 / 1155 |
intestine | 100% | 3644.46 | 965 / 966 | 99% | 83.47 | 523 / 527 |
bladder | 100% | 4432.38 | 21 / 21 | 99% | 92.80 | 498 / 504 |
pancreas | 99% | 1775.34 | 324 / 328 | 100% | 70.05 | 178 / 178 |
adipose | 100% | 3369.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 52.13 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 82.70 | 29 / 29 |
muscle | 100% | 11589.29 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3228.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 138.08 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 58.34 | 1 / 1 |
blood vessel | 100% | 3135.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3063.86 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 1776.94 | 835 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0001701 | Biological process | in utero embryonic development |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_1902883 | Biological process | negative regulation of response to oxidative stress |
GO_0045604 | Biological process | regulation of epidermal cell differentiation |
GO_0071353 | Biological process | cellular response to interleukin-4 |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0010506 | Biological process | regulation of autophagy |
GO_0030496 | Cellular component | midbody |
GO_0034451 | Cellular component | centriolar satellite |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031463 | Cellular component | Cul3-RING ubiquitin ligase complex |
GO_0005884 | Cellular component | actin filament |
GO_0016234 | Cellular component | inclusion body |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0008134 | Molecular function | transcription factor binding |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0097718 | Molecular function | disordered domain specific binding |
GO_0005515 | Molecular function | protein binding |
Gene name | KEAP1 |
Protein name | Kelch-like ECH-associated protein 1 Kelch like ECH associated protein 1 Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19) |
Synonyms | KIAA0132 KLHL19 INRF2 |
Description | FUNCTION: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex that regulates the response to oxidative stress by targeting NFE2L2/NRF2 for ubiquitination . KEAP1 acts as a key sensor of oxidative and electrophilic stress: in normal conditions, the BCR(KEAP1) complex mediates ubiquitination and degradation of NFE2L2/NRF2, a transcription factor regulating expression of many cytoprotective genes . In response to oxidative stress, different electrophile metabolites trigger non-enzymatic covalent modifications of highly reactive cysteine residues in KEAP1, leading to inactivate the ubiquitin ligase activity of the BCR(KEAP1) complex, promoting NFE2L2/NRF2 nuclear accumulation and expression of phase II detoxifying enzymes . In response to selective autophagy, KEAP1 is sequestered in inclusion bodies following its interaction with SQSTM1/p62, leading to inactivation of the BCR(KEAP1) complex and activation of NFE2L2/NRF2 . The BCR(KEAP1) complex also mediates ubiquitination of SQSTM1/p62, increasing SQSTM1/p62 sequestering activity and degradation . The BCR(KEAP1) complex also targets BPTF and PGAM5 for ubiquitination and degradation by the proteasome . . |
Accessions | ENST00000591039.1 ENST00000171111.10 ENST00000585845.1 ENST00000590593.1 K7EQX2 Q14145 K7ESE0 ENST00000592055.2 K7EPZ3 K7EJD8 ENST00000393623.6 ENST00000591419.2 K7EMY1 K7EJ49 ENST00000592478.5 |